Company: EDSA
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001171843-25-005236
Chunk: 99

Company: Edesa Biotech, Inc.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part II, Item 3
Chunk 99
---
32.2*

			Certification of the Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

			101.INS

			Inline XBRL Instance Document

			101.SCH

			Inline XBRL Taxonomy Extension Schema Document

			101.CAL

			Inline XBRL Taxonomy Calculation Linkbase Document

			101.DEF

			Inline XBRL Taxonomy Extension Definition Linkbase Document

			101.LAB

			Inline XBRL Taxonomy Label Linkbase Document

			101.PRE

			Inline XBRL Taxonomy Presentation Linkbase Document

			104

			Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

* The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of Edesa Biotech, Inc. under the Securities Act of 1933, as amended, or the Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Management contract or compensatory plan or arrangement. 

27

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Date: August 8, 2025

			EDESA BIOTECH, INC.

			/s/ Pardeep Nijhawan

			Pardeep Nijhawan, MD, Director, Chief Executive Officer and Corporate Secretary

			(Principal Executive Officer)

			Date: August 8, 2025

			/s/ Peter Weiler

			Peter Weiler, Chief Financial Officer

			(Principal Financial Officer and Duly Authorized Officer)

28